Literature DB >> 12736797

Visceral leishmaniasis presenting as subcutaneous nodules in a HIV-positive patient.

K Göbels1, T Feldt, M Oette, J Richter, G Harms, M P Grobusch, M Sarbia, D Häussinger.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12736797     DOI： 10.1007/s10096-003-0923-5

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN： 0934-9723            Impact factor:   3.267


× No keyword cloud information.
  11 in total

1.  Decline of a visceral leishmaniasis epidemic in HIV-infected patients after the introduction of highly active antiretroviral therapy (HAART).

Authors:  R López-Vélez; J L Casado; V Pintado
Journal:  Clin Microbiol Infect       Date:  2001-07       Impact factor: 8.067

2.  An unusual gastrointestinal presentation of leishmaniasis.

Authors:  M O McBride; M Fisher; C J Skinner; R Golden; J Main
Journal:  Scand J Infect Dis       Date:  1995

3.  Bronchopulmonary and mediastinal leishmaniasis: an unusual clinical presentation of Leishmania donovani infection.

Authors:  B G Marshall; P Kropf; K Murray; C Clark; A M Flanagan; R N Davidson; R J Shaw; I Müller
Journal:  Clin Infect Dis       Date:  2000-05-18       Impact factor: 9.079

4.  Visceral leishmaniasis with pericarditis in an HIV-infected patient.

Authors:  Ali Mofredj; Jean Michel Guerin; Frank Leibinger; Rafik Masmoudi
Journal:  Scand J Infect Dis       Date:  2002

5.  Leishmania in discarded syringes from intravenous drug users.

Authors:  I Cruz; M A Morales; I Noguer; A Rodríguez; J Alvar
Journal:  Lancet       Date:  2002-03-30       Impact factor: 79.321

6.  Oral leishmaniasis in a HIV-positive patient. Report of a case involving the palate.

Authors:  M A Milián; J V Bagán; Y Jiménez; A Pérez; C Scully
Journal:  Oral Dis       Date:  2002-01       Impact factor: 3.511

7.  Relapsing visceral leishmaniasis in HIV-infected patients undergoing successful protease inhibitor therapy.

Authors:  J L Casado; R Lopez-Velez; V Pintado; C Quereda; A Antela; S Moreno
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2001-03       Impact factor: 3.267

8.  Pancreatic involvement in co-infection visceral leishmaniasis and HIV: histological and ultrastructural aspects.

Authors:  E Z Chehter; M A Longo; A A Laudanna; M I Duarte
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2001 Mar-Apr       Impact factor: 1.846

Review 9.  Leishmaniasis.

Authors:  B L Herwaldt
Journal:  Lancet       Date:  1999-10-02       Impact factor: 79.321

10.  Prophylaxis of visceral leishmaniasis in human immunodeficiency virus-infected patients.

Authors:  E Ribera; I Ocaña; J de Otero; E Cortes; I Gasser; A Pahissa
Journal:  Am J Med       Date:  1996-05       Impact factor: 4.965
View more
  1 in total

Review 1.  PKDL and other dermal lesions in HIV co-infected patients with Leishmaniasis: review of clinical presentation in relation to immune responses.

Authors:  Eduard E Zijlstra
Journal:  PLoS Negl Trop Dis       Date:  2014-11-20
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.